Urinary excretion of calcitonin gene-related peptide in males with hot flushes after castration for carcinoma of the prostate

Scandinavian Journal of Urology and Nephrology

Volumn 35, Issue 2, 2001, Pages 92-96

  Wyon, Yvonne ^a   Spetz, Anna Clara ^a   Hammar, Mats ^a   Theodorsson, Elvar ^a   Varenhorst, Eberhard ^b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b Norrkoping Hospital   (Sweden)

Author keywords

Calcitonin gene related peptide; Castration; Hot flushes; Prostatic carcinoma; Vasomotor symptoms

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; GONADORELIN DERIVATIVE; GOSERELIN;

ADULT; AGED; ARTICLE; CASTRATION; CLINICAL ARTICLE; DRUG POTENCY; HISTOPATHOLOGY; HOT FLUSH; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PATHOPHYSIOLOGY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; RADIOIMMUNOASSAY; SWEATING; URINARY EXCRETION; VASODILATATION;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; CALCITONIN GENE-RELATED PEPTIDE; GOSERELIN; HOT FLASHES; HUMANS; MALE; MIDDLE AGED; ORCHIECTOMY; PROSTATIC NEOPLASMS;

EID: 0035000255     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655901750175015     Document Type: Article

References (27)

1. 1. Karling P, Hammar M, Varenhorst E. Prevalence and duration of vasomotor symptoms after surgical or medical castration in men with prostatic carcinoma. J Urol 1994; 152: 1170-3.
2. 2. Cabot AT. The question of castration for enlarged prostate. Am Surg 1896; 24: 265-309.
3. 3. Wardlaw SL, Wehrenberg WB, Frantz AG, Ferin M. Effects of sex steroids on β-endorphin in hypophyseal portal blood. J Clin Endocrinol Metab 1982; 55: 877-81.
4. 4. Frödin T, Ålund G, Varenhorst E. Measurement of skin blood-flow and water evaporation as a means of objectively assessing hot flushes after orchidectomy in patients with prostatic cancer. Prostate 1985; 7: 203-8.
5. 5. Rebar R, Spitzer L. The physiology and measurements of hot flushes. Am J Obstet Gynecol 1987; 156: 1284-8.
6. 6. Freedman RR. Laboratory and ambulatory monitoring of menopausal hot flashes. Psychophysiology 1989; 26: 573-9.
7. 7. Widdowson PS, Griffiths EC, Slater P. Body temperature effects of opioids administered into the periaqueductal grey area of the rat brain. Regul Pept 1983; 7: 259-67.
8. 8. Spencer RL, Hruby VJ, Burks TF. Alteration of thermoregulatory set point with opioid agonists. J Pharmacol Exp Ther 1990; 252: 696-705.
9. 9. Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenco PE, River J, et al. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 1983; 304: 129-35.
10. 10. Uddman R, Edvinsson L, Ekblad E, Håkansson R, Sundler F. Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects. Regul Pept 1986; 15: 1-23.
11. 11. Collin E, Frechilla D, Pohl M, Bourgoin S, Le Bars D, Hamon M, et al. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo. Brain Res 1993; 609: 211-22.
12. 12. Wyon Y, Lindgren R, Lundeberg T, Hammar M. Effects of acupuncture on climacteric vasomotor symptoms, quality of life and urinary excretion of neuropeptides among postmenopausal women. Menopause 1995; 2: 3-12.
13. 13. Theodorsson-Norheim E, Hemsen A, Brodin E, Lundberg JM. Sample handling techniques when analyzing regulatory peptides. Life Sci 1987; 41: 845-8.
14. 14. Varenhorst E, Hammar M. Hot flushes under endocrine treatment and their management. In: Schröder FH, ed. Recent advances in prostate cancer and BPH. Carnfort: Parthenon Publishing, 1996: 133-46.
15. 15. Varenhorst E, Ålund G, Carlström K. Gonadotropine und Nebennierenrindenhormone bei Hitzewallungen nach bilateraler Orchidektomie wegen Prostatakarzinoms. Verhandlungsbericht der Deutschen Gesellschaft für Urologie. 38. Tagung: Springer Verlag, 1986: 135-6.
16. 16. Atala A, Amin M, Harty JI. Diethylstilbestrol in treatment of postorchidectomy vasomotor symptoms and its relationship with serum follicle-stimulating hormone, luteinizing hormone, and testosterone. Urology 1992; 39: 108-10.
17. 17. Hammar M, Berg G, Lindgren R. Does physical exercise influence the frequency of postmenopausal hot flushes? Acta Obstet Gynecol Scand 1990; 69: 409-12.
18. 18. Ivarsson T, Spetz A-C, Hammar M. Physical exercise and vasomotor symptoms in postmenopausal women. Maturitas 1998; 29: 139-46.
19. 19. Nappi C, Petralgia F, Gambardella A, De Masellis G, Di Carlo C, Genazanni AR, et al. Relationship between cerebrospinal fluid β-endorphin and plasma pituitary-gonadal hormone levels in women. J Endocrinol Invest 1990; 13: 149-53.
20. 20. Wehrenberg WB, Wardlaw SL, Frantz AG, Ferin M. β-endorphin in hypophyseal portal blood; variations throughout the menstrual cycle. Endocrinology 1982; 111: 879-82.
21. 21. Petralgia F, Porro C, Facchinetti F, Cicoli C, Bertelli E, Volpe A, et al. Opioid control of LH secretion in human menstrual cycles, menopause and aging reduce the effect of naloxone but not of morphine. Life Sci 1986; 38: 2103-10.
22. 22. Reid RL, Quigley ME, Yen SSC. The disappearance of opioidergic regulation of gonadotropin secretion in postmenopausal women. J Clin Endocrinol Metab 1983; 57: 1107-10.
23. 23. Jernbeck J, Edner M, Dalsgaard C-J, Pernow B. The effect of calcitonin gene-related peptide (CGRP) on human forearm blood flow. Clin Physiol 1990; 10: 335-43.
24. 24. Chen J-T, Hirai Y, Seimiya Y, Hasumi K, Shiraki M. Menopausal flushes and calcitonin-gene-related peptide. Lancet 1993; 342: 49.
25. 25. Valentini A, Petralgia F, De Vita D, Nappi C, Margutti A, Uberti E, et al. Changes of plasma calcitonin gene-related peptide levels in postmenopausal women. Am J Obstet Gynecol 1996; 175: 638-42.
26. 26. Transforini G, Margutti A, Portaluppi F, Menegatti M, Ambrosio MR, Bagni B, et al. Circadian profile of plasma calcitonin gene-related peptide in healthy man. J Clin Endocrinol Metab 1991; 73: 945-51.
27. 27. Wyon Y, Frisk J, Lundeberg T, Theodorsson E, Hammar M. Postmenopausal women with vasomotor symptoms have increased urinary excretion of calcitonin gene-related peptide. Maturitas 1998; 30: 289-94.